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Outline:
• Motivation: Complex diseases as pathway or network perturbations
• Finding disease-associated pathways using omics network analysis 
(software EnrichNet, joint work with Alfonso Valencia CNIO group)
• Using pathway information to improve omics sample classification 
• Application to public omics & GWAS data from Parkinson‘s disease studies
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Motivation: Complex diseases as network perturbations
Alterations in different biomolecules of a cellular pathway or
network can cause similar disruptions downstream
Example: Colorectal carcinoma
• Mutation deactivating APC has the same 
overall effect as mutations preventing degra-
dation of β-catenin (Segditsas et al., 2006)
 GOAL: Analyze alterations at the
level of molecular networks and
pathways to complement single
gene/protein level analyses Wnt/β-catenin signaling pathway
(         = affected by disease-related
mutations)
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Network-based approach to Parkinson’s disease
Mutations in familial PD
PD genetic risk factors
(replicated as significant)
protein-protein interaction
Parkinson‘s disease (PD) as a network perturbation 
• Familial PD: Multiple disease-causing mutations across different genes
• Idiopathic PD: Complex interplay between genetic and environmental risk factors
 interrelate affected genes in molecular networks
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EnrichNet: Network scoring of disease-related pathways
EnrichNet pathway association scoring idea:
 Quantify distances in a molecular network and multiplicity and density of interactions between 
the genes/proteins of interest (considering all possible interconnecting random walks)
Illustration:
target set nodes
(e.g. differentially
expressed genes in   
PD vs. controls)
pathway nodes
other nodes
Case 1:
many, dense
and short inter-
connecting
routes
Case 2:
few, sparse 
and long inter-
connecting
routes
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EnrichNet: Network node relevance scoring
Google “Personalized Page Rank“:
Compute steady-state node visiting
probabilities for random walks:
pt+1 = (1-r) A pt + p0
• A:= network adjacency matrix
• r:= restart probability (here: r = 0.9)
• pit:= probability walker is at node i at time t
target set           target/pathway overlap
pathway 1 pathway 2
 Output: Relevance scores for 
each pathway
 Use distance-weighted aggrega-
tion (Xd-score, Olmea et al. 2009)
Transfer approach to
molecular networks
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EnrichNet: Comparative analysis
Comparative analysis on benchmark microarray data: 
• compare EnrichNet against classical over-representation analysis using benchmark datasets from   
the Broad Institute of MIT and Harvard (5 gene expression datasets and 2 pathway databases)
 EnrichNet provides a consistently higher agreement with benchmark rankings
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EnrichNet: Parkinson’s disease datasets and workflow
Datasets:
• 8 public post mortem brain (substantia nigra) gene expression datasets from PD case-
control studies
• GWAS data from 5 public PD case-control studies
• a genome-scale human protein interaction network (STRING high-confidence network)
• cellular pathway definitions from 5 annotation databases
Omics/GWAS Interactome Pathways
EnrichNet software
Pathway rankings & network visualizations
significance
filter:
Min. size:
10 genes
(FDR < 0.01)
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EnrichNet: Results on Parkinson’s disease data
Top-ranked cellular processes for transcriptomics data (Gene Ontology):
Top-ranked cellular processes for GWAS data (Gene Ontology):
103200.0240.203nervous system development (GO:0007399)
4350.0340.951neurotransmitter transport (GO:0006836)
4290.0241.163response to amphetamine (GO:0001975)
2100.3531.722response to herbicide (GO:0009635)
2100.3531.722neuron maturation (GO:0042551)
3140.0341.851dopamine metabolic process (GO:0042417)
Overlap 
size
Pathway 
size
Fisher 
Q-valueXD-scoreGene Ontology process
2160.5371.082long-term synaptic potentiation (GO:0060291)
2160.5371.082receptor clustering (GO:0043113)
2160.5371.082lipid biosynthetic process (GO:0008610)
2150.5371.157regulation of autophagy (GO:0010506)
2120.5371.457synaptic vesicle endocytosis (GO:0048488)
Overlap 
size
Pathway 
size
Fisher 
Q-valueXD-scoreGene Ontology process
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EnrichNet: Integrate transcriptomics and GWAS data
1810.45710.422cellular response to oxidative stress (GO:0034599)
1810.45710.422branched chain family amino acid catabolic process (GO:0009083)
1610.51910.484positive regulation of synaptic transmission (GO:0050806)
1610.51910.484regulation of neurotransmitter secretion (GO:0046928)
1410.59910.565positive regulation of protein serine/threonine kinase activity (GO:0071902)
1410.59910.565
positive regulation of release of sequestered calcium ion
into cytosol (GO:0051281)
1410.59910.565positive regulation of endocytosis (GO:0045807)
1310.64910.614cellular response to stress (GO:0033554)
1610.51921.047regulation of exocytosis (GO:0017157)
1310.64921.307synaptic transmission, dopaminergic (GO:0001963)
1010.85710.822axon extension (GO:0048675)
1621.08210.484long-term synaptic potentiation (GO:0060291)
1410.59931.851dopamine metabolic process (GO:0042417)
1010.85721.722response to herbicide (GO:0009635)
1221.45710.672synaptic vesicle endocytosis (GO:0048488)
Pathway 
size
GWAS 
overlap
GWAS 
XD-
score
Trans-
criptome 
overlap
Trans-
criptome 
XD-score
Gene Ontology process
Combine rankings for transcriptomics and GWAS data (using the sum of standardized scores)
 Joint top-ranked cellular processes (Gene Ontology):
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EnrichNet: Network visualization for top-ranked GO term
Largest connected network component for “Synaptic vesicle endocytosis” GO process
Transcriptome-derived
GWAS-derived  
GO process member
previous qPCR      
validation reported







Mutation associated with
early-onset parkinsonism
(Quadri et al., 2013; Krebs et al., 2013)
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EnrichNet: Network visualization example
Largest connected network component for “EPHA2 forward signaling” pathway (PID)





Transcriptome-derived
GWAS-derived  
GO process member
previous qPCR      
validation reported
involved in neurite outgrowth,
strongly under-expressed in PD
Injection of 
clustered ephrins 
into rat brains with 
6-OHDA lesions 
reported to have  
protective effects 
(Jing et al., 2012)
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Using pathway information for sample classification
Question: Disease-associated expression alterations are often localized in
pathways / network clusters – can we use this information to build 
more robust classification models for biomarker development?
Idea: Collect a dictionary of pathway-level predictive features (“fingerprints“) to build
machine learning classifiers for omics data (e.g. using mean or variance of
expression in pathway, PCA / MDS components of pathway expression)
Example of localized 
transcriptome changes in PD
(data by Zhang et al., 2005):
Over-expressed in PD
Under-expressed in PD
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Pathway-level sample classification: Cross-validation
Sample classification results on PD brain transcriptomic data
 map dataset by Moran et al. (2006) onto Gene Ontology (GO) processes
 use empirical Bayes moderated T-test to select attributes (“pathway fingerprints“)
and a linear Support Vector Machine for classification (10-fold cross-validation)
87.5 ± 17.784.2 ± 18.286.7 ± 18.591.7 ± 13.6GO - MDS
95 ± 10.592.5 ± 12.195 ± 10.589.2 ± 14.2GO - PCA
84.2 ± 18.290 ± 12.984.2 ± 13.981.7 ± 17.5GO - Max.
71.7 ± 24.979.2 ± 23.368.3 ± 25.171.7 ± 21.9GO - Min.
86.7 ± 14.379.2 ± 20.181.7 ± 17.576.7 ± 18.8GO - Stddev.
91.7 ± 13.695 ± 10.591.7 ± 13.684.2 ± 13.9GO - Median
89.2 ± 14.292.5 ± 12.190 ± 12.984.2 ± 13.9GO - Mean
92.5 ± 12.192.5 ± 12.189.2 ± 14.289.2 ± 14.2Gene-level model
100503010Attribute type
Accuracy and stddev. for different numbers of selected attributes
Model limitations:  1) post-mortem samples;  2) tissue-specific (brain, substantia nigra)
3) no disease controls (PD vs. unaffected)
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Visualizing the pathways with most predictive changes
Example: Notch signaling pathway (Wikipathways)
 identify pathways which are both enriched in gene activity alterations and contain
predictive information for sample classification
 select representative genes for qPCR validation (iterative refinement of prediction 
models)
under-expressed in PD
over-expressed in PD 
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Summary
• We present a software, EnrichNet, for the integrated pathway and network 
analysis of disease-related omics data
• On public transcriptomics and GWAS datasets for Parkinson‘s disease, the 
approach identifies new statistically significant pathway associations (not 
detected with classical overlap-based approach)
• The pathway information can be used to improve machine learning models for 
omics sample classification
Software available at: www.enrichnet.org
pathvar.embl.de
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